首页 | 本学科首页   官方微博 | 高级检索  
     

必可酮配伍思密达防治放射性口腔炎的临床观察
引用本文:袁响林,胡国清,胡长耀,于世英,肖仁兰. 必可酮配伍思密达防治放射性口腔炎的临床观察[J]. 临床口腔医学杂志, 2002, 18(1): 45-46
作者姓名:袁响林  胡国清  胡长耀  于世英  肖仁兰
作者单位:430030,湖北,武汉,华中科技大学同济医院肿瘤科
摘    要:目的 观察必可酮配伍思密达防治放射性口腔炎的疗效。方法 88例头颈部肿瘤放疗患者随机分成治疗组与对照组各44例,治疗组采用必可酮配伍思密达,对照组采用朵贝氏液及VitB1治疗。结果 治疗组口腔炎发生率38.6%,对照组为59.1%;治疗组3、4级口腔炎发生率为6.8%,二者均有统计学差异(P<0.01)。结论 必可酮配伍思密达是防治放射性口腔炎的一种有效方法。

关 键 词:必可酮 思密达 放射性口腔炎 防治 配伍
文章编号:1003-1634(2002)01-0045-02

Clinical observation of effects of beconase combined with smecta to alleviate radiation-induced oral mucositis
YUAN Xiang lin,HU Guo qing,HU Chang yiao,et al.. Clinical observation of effects of beconase combined with smecta to alleviate radiation-induced oral mucositis[J]. Journal of Clinical Stomatology, 2002, 18(1): 45-46
Authors:YUAN Xiang lin  HU Guo qing  HU Chang yiao  et al.
Affiliation:YUAN Xiang lin,HU Guo qing,HU Chang yiao,et al.Department of Oncology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
Abstract:Objective To observe the effect of Beconase combined with Smecta to alleviate radiation induced oral mucositis. Methods 88 patients with carcinoma in head and neck were randomized into two groups. The study group (44 cases) was treated by Smecta combined with Beconase. The control group (44 cases) was received Dobell's sol plus vitB 1 . Results Mucositis was 38.6 %(17/44) in study group, 59.1 %(26/44) in the control group, respectively. Grade 3 and grade 4 mucositis was 6.8 %(3/44) in the study group, 38.6 %(17/44) in the control group, respectively, ( P < 0.01 ). Conclusion Beconase combined with Smecta is a effective method to alleviate radiation induced oral mucositis.
Keywords:Smecta  Beconase  radiotherapy mucositis  prevention and treatment
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号